Viewing Study NCT06400251


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-04 @ 4:25 AM
Study NCT ID: NCT06400251
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Lymphoma View
None Advanced Malignant Solid Neoplasm View
None Refractory Lymphoma View
None Refractory Malignant Solid Neoplasm View
None Refractory Multiple Myeloma View
Keywords: